The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Cardiac Valve Market By 2030 Starting From Its 2026 Size?
The cardiac valve market size has seen rapid expansion over recent years. It is anticipated to grow from $12.41 billion in 2025 to $14.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. The growth observed in previous periods can be attributed to an increased occurrence of valvular heart diseases, the broadening of cardiac surgery programs, a rising utilization of mechanical heart valves, innovations in surgical valve techniques, and enhanced availability of cardiac care facilities.
The cardiac valve market size is anticipated to experience rapid growth in the coming years, with projections indicating it will reach $24.02 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. This expansion during the forecast period is attributable to several factors, including increasing demand for transcatheter interventions, a rising focus on elderly cardiac care, the expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, and the increasing adoption of patient-specific valve solutions. Significant trends expected in the forecast period encompass an increasing adoption of transcatheter valve procedures, a rising demand for bioprosthetic heart valves, a growing preference for minimally invasive valve replacement, the expansion of advanced valve repair techniques, and an enhanced focus on valve durability and performance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp
What Drivers Are Shaping The Future Growth Of The Cardiac Valve Market?
The rising occurrence of cardiovascular diseases is projected to fuel the expansion of the cardiac valve market. The prevalence of cardiovascular disease has progressively increased due to factors such as smoking, obesity, a lack of physical activity, and other stressors on the cardiovascular system. The most common cause of coronary artery disease involves the buildup of fatty plaques in the arteries. These gradual increases in heart-related conditions have heightened the demand for cardiac valves to treat heart valve problems. For instance, in October 2024, the Centers for Disease Control, a US-based government agency, reported that in 2023, approximately 919,032 people died from cardiovascular disease, which accounted for 1 in every 3 deaths. Thus, the increasing incidence of cardiovascular diseases will drive the growth of the cardiac valve market.
Which Segment Categories Define The Cardiac Valve Market?
The cardiac valve market covered in this report is segmented –
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
What Major Market Trends Are Driving Changes In The Cardiac Valve Market?
Major companies engaged in the cardiac valve market are prioritizing the development of technological innovations, such as transfemoral transcatheter mitral valve replacement (TMVR) systems, to cater to the growing demand for less invasive therapies among an aging population experiencing rising instances of mitral regurgitation. A transfemoral TMVR system functions by utilizing a collapsible frame and biologic valve leaflets, which are delivered through a catheter via the femoral vein, thus avoiding open-heart surgery and leading to shorter recovery periods, lower procedural risks, and greater suitability for patients deemed ineligible for traditional surgery. As an illustration, in April 2025, Edwards Lifesciences, a U.S.-based medical device company, secured CE Mark approval for its SAPIEN M3 System, marking the inaugural transcatheter mitral valve replacement therapy delivered using a transfemoral method. The SAPIEN M3 incorporates a docking mechanism that first stabilizes the native mitral leaflets and chordae by pulling them inward to create a secure landing zone, subsequently followed by the deployment of a bioprosthetic valve, with both components delivered through a steerable 29 F guide sheath. This design permits precise positioning, readjustment, and retrieval prior to its final deployment, thereby boosting procedural safety and extending treatment possibilities to patients for whom surgery or edge-to-edge repair is not suitable.
Who Are The Top Companies Competing In The Cardiac Valve Market?
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl
Read the full cardiac valve market report here:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report
Which Geographic Regions Are Influencing Demand In The Cardiac Valve Market?
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cardiac Valve Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp
Browse Through More Reports Similar to the Global Cardiac Valve Market 2026, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Market Report 2026
Cardiovascular Surgery Devices And Equipment Market Report 2026
Cardiovascular Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model